Skip to main navigation Skip to search Skip to main content

Perioperative preparation for head and neck cancer patients receiving immunotherapy

  • Shao Chun Wu
  • , Kuan Hao Liao
  • , Pi Chieh Lin
  • , Ching Hua Hsieh*
  • *Corresponding author for this work
  • Chang Gung University

Research output: Contribution to journal › Review article › peer-review

Abstract

Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has significantly advanced the management of head and neck cancers (HNCs), and is increasingly integrated into perioperative strategies. This review addresses perioperative considerations essential for HNC patients undergoing surgery following neoadjuvant or adjuvant ICIs. Key perioperative issues include the optimal timing of surgery relative to immunotherapy, recognition and management of immune-related adverse events (irAEs), potential wound healing complications, infection risks, and anesthesia considerations. Neoadjuvant ICIs administered approximately 3–6 weeks before surgery are feasible without substantial delays or increased morbidity. Adjuvant ICIs typically begin 4–8 weeks postoperatively once adequate healing occurs, with careful integration alongside standard postoperative therapies like radiotherapy and chemotherapy. Common irAEs, including dermatologic, endocrine, pulmonary, cardiac, gastrointestinal, and renal complications, necessitate targeted preoperative screening and proactive management strategies. Multidisciplinary coordination is essential to minimize perioperative risks, with standardized protocols recommended for patient assessment, intraoperative management, and postoperative monitoring. Current evidence suggests that immunotherapy, while posing unique perioperative challenges, does not substantially elevate surgical risks if adequately managed.

Original languageEnglish
Pages (from-to)652-660
Number of pages9
JournalAsian Journal of Surgery
Volume49
Issue number2
DOIs
StatePublished - 02 2026

Bibliographical note

Publisher Copyright:
© 2026 Asian Surgical Association and Taiwan Society of Coloproctology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Checkpoint inhibitors
  • Head and neck cancer
  • Immune-related adverse events
  • Immunotherapy
  • Perioperative management

Fingerprint

Dive into the research topics of 'Perioperative preparation for head and neck cancer patients receiving immunotherapy'. Together they form a unique fingerprint.

Cite this